Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38076
CAS Number:
108612-45-9
Mizolastine
Purity:
≥ 98 % (dosage par titration, HPLC)
Documents
$186.98 /1G
Taille
Request Bulk Quote
Informations sur le produit

Mizolastine is a potent antihistamine known for its effectiveness in treating allergic conditions such as rhinitis and urticaria. This compound operates by selectively blocking H1 receptors, thereby alleviating symptoms like sneezing, itching, and nasal congestion. Its unique structure, featuring a benzimidazole core, enhances its affinity for histamine receptors, making it a preferred choice in allergy management. Mizolastine is particularly valued in the pharmaceutical industry for its long-lasting effects and minimal sedative properties, which allow patients to maintain their daily activities without drowsiness.

In addition to its primary use in allergy treatment, Mizolastine has shown potential in various research applications, including studies on its anti-inflammatory properties. Researchers are exploring its role in managing conditions beyond allergies, such as asthma and chronic inflammatory diseases. Its favorable pharmacokinetic profile, including rapid absorption and extended half-life, positions Mizolastine as a versatile compound in both clinical and research settings, making it an essential addition to any pharmaceutical formulation or research project focused on histamine-related conditions.

Numéro CAS 
108612-45-9
Formule moléculaire
C 24 H 25 FN 6 O
Poids moléculaire 
432.5
Point de fusion 
222 - 226 °C
Informations générales
Numéro CAS 
108612-45-9
Formule moléculaire
C 24 H 25 FN 6 O
Poids moléculaire 
432.5
Point de fusion 
222 - 226 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Mizolastine is widely utilized in research focused on:

  • Allergy Treatment: Commonly used as an antihistamine, it effectively alleviates symptoms of allergic rhinitis and urticaria, providing relief to millions suffering from seasonal allergies.
  • Pharmaceutical Development: Researchers explore its structure and mechanism of action to develop new antihistamines with improved efficacy and fewer side effects, enhancing patient outcomes.
  • Clinical Trials: Frequently involved in clinical studies assessing its effectiveness in treating allergic conditions, helping to gather data for regulatory approvals and clinical guidelines.
  • Comparative Studies: Used in research comparing its effects with other antihistamines, offering insights into its unique benefits, such as a lower sedative effect compared to older medications.
  • Formulation Research: Investigated for its potential in combination therapies, where it may enhance the effectiveness of other drugs, providing a multi-faceted approach to allergy management.

Citations